PWT33597 Mesylate

PWT33597 mesylate · Pathway Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PWT33597 Mesylate, covering 2012-10-25 to 2012-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of PWT33597 Mesylate in Subjects With Advanced Malignancies [Phase 1]